CBP Officers Seize More Than a Ton of Methamphetamine in Medical Supply Shipment
SAN DIEGO – U.S. Customs and Border Protection officers at the Otay Mesa Commercial Facility seized close to 2,500 pounds of methamphetamine concealed in a shipment of medical supplies.
On Saturday, May 15, at approximately 9:45 a.m., a driver entered the Otay Mesa Commercial Facility with a tractor-trailer shipment. The cargo was manifested as various medical supplies. A team of CBP officers were roving through the lanes of trucks that had entered the port and were waiting for their inspection. One CBP officer targeted the truck, driver, and shipment for a more intensive inspection. The officer referred the driver, truck, and shipment for an x-ray screening.
CBP officers screened the truck using the port’s imaging system and found anomalies within the cargo shipment. The truck was moved to an inspection dock where a CBP officer with a canine screened the boxes of cargo; the dog alerted to one of the pallets of medical products. Officers offloaded the shipment and discovered 120 packages comingled with various medical supplies.
CBP officers extracted approximately 2,425 pounds of methamphetamine worth an estimated $5.5 million. CBP officers seized the narcotics and conveyance. The driver, a 29-year-old Mexican male, was arrested and turned over to U.S. Immigration and Customs Enforcement, Homeland Security Investigations. The driver is facing federal charges and has been transported to the Metropolitan Correctional Center.
“Most of what CBP officers see every day is legitimate travelers and legitimate cargo that needs to speed its way into the U.S. as a critical part of our economy.” said Anne Maricich, acting CBP Director of Field Operations in San Diego. “But CBP officers know that we must remain vigilant; transnational criminal organizations will attempt any avenue they can think of to try and smuggle their illicit drugs into the U.S.”
Content created by Conservative Daily News is available for re-publication without charge under the Creative Commons license. Visit our syndication page for details and requirements.